Abbott India Limited (IN:ABBOTINDIA)
:ABBOTINDIA
ABBOTINDIA Stock Chart & Stats
₹28101.15
₹188.10(0.64%)
At close: 4:00 PM EST
₹28101.15
₹188.10(0.64%)
Day’s Range― - ―
52-Week Range₹25,350.00 - ₹35,921.55
Previous CloseN/A
Volume5.43K
Average Volume (3M)628.00
Market Cap
₹548.21B
Enterprise Value₹543.72B
Total Cash (Recent Filing)₹23.42B
Total Debt (Recent Filing)₹1.82B
Price to Earnings (P/E)41.0
Beta0.62
Next Earnings
May 19, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield1.68%
Share Statistics
EPS (TTM)189.00
Shares Outstanding21,249,302
10 Day Avg. Volume806
30 Day Avg. Volume628
Financial Highlights & Ratios
PEG Ratio2.57
Price to Book (P/B)15.22
Price to Sales (P/S)10.06
P/FCF Ratio67.16
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
₹32,150.00Price Target Upside14.41% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)820.16
Revenue Forecast (FY)₹75.63B
Bulls Say, Bears Say
Bulls Say
Balance Sheet StrengthLow leverage and a strong equity base provide durable financial flexibility: the company can fund salesforce investment, product support, or opportunistic M&A without relying on expensive external financing. This resilience supports operations through sector cycles and regulatory shocks over the next 2–6 months.
Consistent Free Cash FlowStable free cash flow conversion gives the company the ability to reinvest in marketing, new product launches, or return capital to shareholders while maintaining liquidity. Reliable cash generation also reduces refinancing risk and supports durable funding of growth initiatives and working capital needs.
Robust Profitability And MarginsHealthy gross and net margins reflect efficient cost control and pricing power from a branded portfolio. Durable margin structure supports sustained EBIT/EBITDA generation, enabling reinvestment in sales and R&D and providing a buffer against pricing or input-cost pressures over a multi-month horizon.
Bears Say
Moderate Revenue GrowthMid-single-digit top-line growth is modest for a branded-pharma player; without accelerated new product introductions or geographic diversification, revenue momentum may limit scale benefits and constrain faster margin expansion or meaningful market-share gains over the next several months.
Slight Decline In Operating Cash FlowA falling trend in operating cash flow, even if slight, can erode free cash flow sustainability if it persists. That would constrain discretionary capital allocation for marketing, product launches, and shareholder distributions and could force trade-offs between growth investments and returns.
Concentration In Indian Branded Prescription MarketHeavy reliance on a single-country branded prescription model exposes the company to Indian pricing regulation, competitive generic entry, and local reimbursement shifts. Geographic concentration reduces diversification and raises structural execution risk for sustaining growth and margins over coming months.
ABBOTINDIA FAQ
What was Abbott India Limited’s price range in the past 12 months?
Abbott India Limited lowest stock price was ₹25350.00 and its highest was ₹35921.55 in the past 12 months.
What is Abbott India Limited’s market cap?
Abbott India Limited’s market cap is ₹548.21B.
When is Abbott India Limited’s upcoming earnings report date?
Abbott India Limited’s upcoming earnings report date is May 19, 2026 which is in 39 days.
How were Abbott India Limited’s earnings last quarter?
Abbott India Limited released its earnings results on Feb 12, 2026. The company reported ₹189 earnings per share for the quarter, beating the consensus estimate of ₹185 by ₹4.
Is Abbott India Limited overvalued?
According to Wall Street analysts Abbott India Limited’s price is currently Undervalued.
Does Abbott India Limited pay dividends?
Abbott India Limited pays a Annually dividend of ₹475 which represents an annual dividend yield of 1.68%. See more information on Abbott India Limited dividends here
What is Abbott India Limited’s EPS estimate?
Abbott India Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Abbott India Limited have?
Abbott India Limited has 21,249,302 shares outstanding.
What happened to Abbott India Limited’s price movement after its last earnings report?
Abbott India Limited reported an EPS of ₹189 in its last earnings report, beating expectations of ₹185. Following the earnings report the stock price went down -0.778%.
Which hedge fund is a major shareholder of Abbott India Limited?
Currently, no hedge funds are holding shares in IN:ABBOTINDIA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Abbott India Limited
Abbott India Limited operates as a pharmaceutical company in India. It offers pharmaceutical products for various therapeutic areas, such as women's health, gastroenterology, metabolic, central nervous system, pain management, pre-term labor, vitamins, insomnia, vaccines, consumer health, etc. The company was formerly known as Knoll Pharmaceuticals Limited and changed its name to Abbott India Limited in July 2002. Abbott India Limited was incorporated in 1944 and is headquartered in Mumbai, India. Abbott India Limited is a subsidiary of Abbott Capital India Limited.
ABBOTINDIA Stock 12 Month Forecast
Average Price Target
₹32,150.00
▲(14.41% Upside)
Technical Analysis
Aurobindo Pharma Ltd
―
Biocon Limited
―
GlaxoSmithKline Pharmaceuticals Limited
―
Lupin Limited
―
Zydus Lifesciences Limited
―